Lemos BR - Search Results

1

Temperature programmed CVD: a novel technique to investigate carbon nanotube synthesis on FeMo/MgO catalysts.

Teixeira AP, Lemos BR, Magalhães LA, Ardisson JD, Lago RM, Furtado CA, Santos AP. Teixeira AP, et al. Among authors: lemos br. J Nanosci Nanotechnol. 2012 Mar;12(3):2661-7. doi: 10.1166/jnn.2012.5783. J Nanosci Nanotechnol. 2012. PMID: 22755105

2

Growth of carbon structures on chrysotile surface for organic contaminants removal from wastewater.

Lemos BRS, Soares ÉAR, Teixeira APC, Ardisson JD, Fernandez-Outon LE, Amorim CC, Lago RM, Moura FCC. Lemos BRS, et al. Chemosphere. 2016 Sep;159:602-609. doi: 10.1016/j.chemosphere.2016.06.022. Epub 2016 Jun 22. Chemosphere. 2016. PMID: 27343867 Free article.

3

Effects of hydroxyapatite on PMMA-HAp cement for biomedical applications.

Montaño CJ, Campos TPR, Lemos BRS, Yoshida MI, Almeida NGS, Aguilar MTP, Lima CV. Montaño CJ, et al. Among authors: lemos brs. Biomed Mater Eng. 2020;31(3):191-201. doi: 10.3233/BME-206001. Biomed Mater Eng. 2020. PMID: 32568169

4

Eliminating Potential Effects of Other Infections During Selection of Nonhuman Primates for COVID-19 Research.

Andrade MCR, Lemos BRP, Silva LM, Pecotte JK. Andrade MCR, et al. Among authors: lemos brp. Comp Med. 2023 Feb 1;73(1):45-57. doi: 10.30802/AALAS-CM-21-000086. Epub 2023 Jan 4. Comp Med. 2023. PMID: 36744555 Free PMC article. Review.

5

Morphometry of cryopreserved organs from the gastrointestinal system of squirrel monkeys (Saimiri sciureus, Linnaeus, 1758) for improvement of management.

Andrade MCR, Lemos BRP, de Araújo Lopes CA, de Jesus Barbosa Ribeiro M, da Silva LM, Knackfuss FB, Viana CF. Andrade MCR, et al. Among authors: lemos brp. J Med Primatol. 2023 Feb;52(1):34-44. doi: 10.1111/jmp.12618. Epub 2022 Aug 30. J Med Primatol. 2023. PMID: 36039638

6

CRISPR/Cas9 cleavages in budding yeast reveal templated insertions and strand-specific insertion/deletion profiles.

Lemos BR, Kaplan AC, Bae JE, Ferrazzoli AE, Kuo J, Anand RP, Waterman DP, Haber JE. Lemos BR, et al. Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2040-E2047. doi: 10.1073/pnas.1716855115. Epub 2018 Feb 13. Proc Natl Acad Sci U S A. 2018. PMID: 29440496 Free PMC article.

7

AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.

Harris MS, Hartman D, Lemos BR, Erlich EC, Spence S, Kennedy S, Ptak T, Pruitt R, Vermeire S, Fox BS. Harris MS, et al. Among authors: lemos br. J Crohns Colitis. 2016 Jun;10(6):631-40. doi: 10.1093/ecco-jcc/jjw036. Epub 2016 Jan 28. J Crohns Colitis. 2016. PMID: 26822613 Clinical Trial.

8

Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.

Hartman DS, Tracey DE, Lemos BR, Erlich EC, Burton RE, Keane DM, Patel R, Kim S, Bhol KC, Harris MS, Fox BS. Hartman DS, et al. Among authors: lemos br. J Crohns Colitis. 2016 Jun;10(6):641-9. doi: 10.1093/ecco-jcc/jjw026. Epub 2016 Jan 22. J Crohns Colitis. 2016. PMID: 26802087 Clinical Trial.

9

AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease.

Bhol KC, Tracey DE, Lemos BR, Lyng GD, Erlich EC, Keane DM, Quesenberry MS, Holdorf AD, Schlehuber LD, Clark SA, Fox BS. Bhol KC, et al. Among authors: lemos br. Inflamm Bowel Dis. 2013 Oct;19(11):2273-81. doi: 10.1097/MIB.0b013e3182a11958. Inflamm Bowel Dis. 2013. PMID: 23949620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters